X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs NOVARTIS - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS NOVARTIS J.B.CHEMICALS/
NOVARTIS
 
P/E (TTM) x 14.8 363.5 4.1% View Chart
P/BV x 2.3 17.9 13.0% View Chart
Dividend Yield % 0.2 1.6 10.3%  

Financials

 J.B.CHEMICALS   NOVARTIS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
NOVARTIS
Mar-16
J.B.CHEMICALS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs318982 32.4%   
Low Rs200556 35.9%   
Sales per share (Unadj.) Rs148.0252.9 58.5%  
Earnings per share (Unadj.) Rs19.162.1 30.7%  
Cash flow per share (Unadj.) Rs23.963.3 37.8%  
Dividends per share (Unadj.) Rs0.5010.00 5.0%  
Dividend yield (eoy) %0.21.3 14.9%  
Book value per share (Unadj.) Rs128.9363.6 35.5%  
Shares outstanding (eoy) m84.8231.96 265.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.0 57.5%   
Avg P/E ratio x13.612.4 109.6%  
P/CF ratio (eoy) x10.812.2 88.9%  
Price / Book Value ratio x2.02.1 94.9%  
Dividend payout %2.616.1 16.3%   
Avg Mkt Cap Rs m21,95124,580 89.3%   
No. of employees `0002.70.8 363.6%   
Total wages/salary Rs m1,8411,801 102.2%   
Avg. sales/employee Rs Th4,590.910,748.9 42.7%   
Avg. wages/employee Rs Th673.42,395.2 28.1%   
Avg. net profit/employee Rs Th592.12,641.1 22.4%   
INCOME DATA
Net Sales Rs m12,5518,083 155.3%  
Other income Rs m542829 65.3%   
Total revenues Rs m13,0938,913 146.9%   
Gross profit Rs m2,055234 877.3%  
Depreciation Rs m41237 1,123.7%   
Interest Rs m962 5,316.7%   
Profit before tax Rs m2,0881,025 203.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m469752 62.4%   
Profit after tax Rs m1,6191,986 81.5%  
Gross profit margin %16.42.9 565.0%  
Effective tax rate %22.573.4 30.6%   
Net profit margin %12.924.6 52.5%  
BALANCE SHEET DATA
Current assets Rs m7,77812,678 61.3%   
Current liabilities Rs m4,3582,433 179.1%   
Net working cap to sales %27.2126.7 21.5%  
Current ratio x1.85.2 34.2%  
Inventory Days Days5533 167.2%  
Debtors Days Days8022 355.9%  
Net fixed assets Rs m5,71369 8,255.3%   
Share capital Rs m170160 106.1%   
"Free" reserves Rs m10,54711,460 92.0%   
Net worth Rs m10,93711,621 94.1%   
Long term debt Rs m00-   
Total assets Rs m15,57414,400 108.2%  
Interest coverage x22.8570.5 4.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 143.6%   
Return on assets %11.013.8 79.7%  
Return on equity %14.817.1 86.6%  
Return on capital %20.023.6 84.7%  
Exports to sales %48.70.7 6,541.6%   
Imports to sales %7.118.6 38.1%   
Exports (fob) Rs m6,11560 10,157.6%   
Imports (cif) Rs m8891,503 59.1%   
Fx inflow Rs m6,169186 3,311.3%   
Fx outflow Rs m1,2851,821 70.6%   
Net fx Rs m4,884-1,635 -298.8%   
CASH FLOW
From Operations Rs m1,3972,531 55.2%  
From Investments Rs m-320-8,270 3.9%  
From Financial Activity Rs m-1,196-386 310.0%  
Net Cashflow Rs m-102-6,125 1.7%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 3.4 2.0 169.5%  
FIIs % 3.9 1.6 243.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 21.5 172.1%  
Shareholders   30,437 41,647 73.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; PSU & Healthcare Stocks Top Losers(09:30 am)

Asian equities are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.20% while the Hang Seng is up 0.61%. The Shanghai Composite is trading up by 0.45%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 20, 2018 11:51 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - ORCHID PHARMA LTD COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS